Literature DB >> 24034664

The current status of angioplasty of atherosclerotic renal artery stenosis for the treatment of hypertension.

Steven G Chrysant1.   

Abstract

Atherosclerotic renal artery stenosis, a fairly common disease of older persons, is a manifestation of generalized atherosclerosis, and is often associated with coronary artery disease. It is frequently associated with hypertension and impaired renal function, and is perceived by many physicians to be the cause of hypertension and renal failure. For this reason, they believe that hypertension can be cured by performing percutaneous renal artery angioplasty (PTRA) with stent placement. This practice has led to an increase in angioplasties, especially by interventional cardiologists, although the results from several randomized studies comparing interventional therapy with medical therapy have shown no significant difference between the two treatment modalities in blood pressure reduction or change in renal function. Similar results have been found by nonrandomized trials with selective PTRA. For this review, a Medline search of the English literature was conducted from 2006 to 2012, and 13 pertinent studies were selected. These studies with collateral literature will be discussed in this concise review. ©2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24034664      PMCID: PMC8033874          DOI: 10.1111/jch.12161

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  36 in total

Review 1.  Renovascular hypertension: balancing the controversies in diagnosis and treatment.

Authors:  Vesna D Garovic; Garvan C Kane; Gary L Schwartz
Journal:  Cleve Clin J Med       Date:  2005-12       Impact factor: 2.321

2.  Treatment of atherosclerotic renal artery stenosis: time for a new approach.

Authors:  Peter W de Leeuw; Cornelis T Postma; Abraham A Kroon
Journal:  JAMA       Date:  2013-02-20       Impact factor: 56.272

3.  Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis.

Authors:  Philip A Kalra; Haifeng Guo; Annamaria T Kausz; David T Gilbertson; Jiannong Liu; Shu-Cheng Chen; Areef Ishani; Allan J Collins; Robert N Foley
Journal:  Kidney Int       Date:  2005-07       Impact factor: 10.612

4.  The effect of revascularization of atherosclerotic renal artery stenosis on coronary flow reserve and peripheral endothelial function.

Authors:  N Koivuviita; R Tertti; M Luotolahti; O Raitakari; T Vahlberg; P Nuutila; J Knuuti; K Metsärinne
Journal:  Nephron Clin Pract       Date:  2010-12-24

5.  Significant reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: results from the HERCULES trial.

Authors:  Michael R Jaff; Mark Bates; Timothy Sullivan; Jeffrey Popma; Xingyu Gao; Margo Zaugg; Patrick Verta
Journal:  Catheter Cardiovasc Interv       Date:  2012-06-27       Impact factor: 2.692

6.  Renal artery stenting slows the rate of renal function decline.

Authors:  Zachary Arthurs; Benjamin Starnes; Daniel Cuadrado; Vance Sohn; Howard Cushner; Charles Andersen
Journal:  J Vasc Surg       Date:  2007-04       Impact factor: 4.268

7.  Predictive factors and therapeutic approach of renovascular disease: four years' follow-up.

Authors:  Stavroula Ziakka; Michaela Ursu; Dimitris Poulikakos; Christophoros Papadopoulos; Filippos Karakasis; Nikolaos Kaperonis; Nicolas Papagalanis
Journal:  Ren Fail       Date:  2008       Impact factor: 2.606

8.  Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial.

Authors:  Liesbeth Bax; Arend-Jan J Woittiez; Hans J Kouwenberg; Willem P T M Mali; Erik Buskens; Frederik J A Beek; Branko Braam; Frans T M Huysmans; Leo J Schultze Kool; Matthieu J C M Rutten; Cornelius J Doorenbos; Johannes C N M Aarts; Ton J Rabelink; Pierre-François Plouin; Alain Raynaud; Gert A van Montfrans; Jim A Reekers; Anton H van den Meiracker; Peter M T Pattynama; Peter J G van de Ven; Dammis Vroegindeweij; Abraham A Kroon; Michiel W de Haan; Cornelis T Postma; Jaap J Beutler
Journal:  Ann Intern Med       Date:  2009-05-04       Impact factor: 25.391

9.  Clinical efficacy of percutaneous renal revascularization with stent placement in hypertension among patients with atherosclerotic renovascular diseases.

Authors:  Seyed Mohammad Hassan Adel; Seyed Masood Syeidian; Mohammad Najafi; Mohammad Nourizadeh
Journal:  J Cardiovasc Dis Res       Date:  2011-01

10.  STUDIES ON EXPERIMENTAL HYPERTENSION : I. THE PRODUCTION OF PERSISTENT ELEVATION OF SYSTOLIC BLOOD PRESSURE BY MEANS OF RENAL ISCHEMIA.

Authors:  H Goldblatt; J Lynch; R F Hanzal; W W Summerville
Journal:  J Exp Med       Date:  1934-02-28       Impact factor: 14.307

View more
  3 in total

Review 1.  Treatment of hypertension in patients with renal artery stenosis due to fibromuscular dysplasia of the renal arteries.

Authors:  Steven G Chrysant; George S Chrysant
Journal:  Cardiovasc Diagn Ther       Date:  2014-02

2.  Proper patient selection yields significant and sustained reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: long-term results from the HERCULES trial.

Authors:  George S Chrysant; Mark C Bates; Timothy M Sullivan; William B Bachinsky; Jeffrey J Popma; Lei Peng; Hend L Omran; Michael R Jaff
Journal:  J Clin Hypertens (Greenwich)       Date:  2014-06-07       Impact factor: 3.738

Review 3.  The current status of angioplasty of atherosclerotic renal artery stenosis for the treatment of hypertension.

Authors:  Steven G Chrysant
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-07-16       Impact factor: 3.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.